SEC Form 4 · accession 0001312326-15-000002
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas W Baxter
Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 17, 2015 · 2:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Dec 16, 2015 | A | 20,000 | — | A | 220,000 | D | |
| Common Shares | holding | — | — | — | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $0.32 | Jul 11, 2011 | A | 15,000 | A | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 15,000 | 165,000 | D |
| Stock OptionsF1,F2 | $0.10 | Dec 23, 2014 | A | 10,000 | A | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 10,000 | 275,000 | D |
| Stock OptionsF2 | $0.32 | holding | — | — | — | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 150,000 | 150,000 | D |
| Stock OptionsF2 | $0.10 | holding | — | — | — | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 100,000 | 265,000 | D |
Explanation of responses
- F1Adjusted to forward 1.1 split
- F2Adjusted price to forward 1.1 split